Brokerages predict that Tenet Healthcare Corp (NYSE:THC) will announce sales of $4.49 billion for the current quarter, Zacks reports. Nine analysts have provided estimates for Tenet Healthcare’s earnings, with the lowest sales estimate coming in at $4.26 billion and the highest estimate coming in at $4.53 billion. Tenet Healthcare reported sales of $4.98 billion during the same quarter last year, which indicates a negative year over year growth rate of 9.8%. The firm is expected to issue its next earnings results on Monday, February 25th.
According to Zacks, analysts expect that Tenet Healthcare will report full year sales of $18.18 billion for the current financial year, with estimates ranging from $17.96 billion to $18.22 billion. For the next year, analysts forecast that the firm will post sales of $17.87 billion, with estimates ranging from $17.01 billion to $18.44 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of analysts that that provide coverage for Tenet Healthcare.
Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Monday, November 5th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.18. The business had revenue of $4.49 billion during the quarter, compared to analyst estimates of $4.37 billion. Tenet Healthcare had a negative net margin of 0.61% and a positive return on equity of 47.38%. The firm’s revenue was down 2.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.17) earnings per share.
Several large investors have recently added to or reduced their stakes in THC. Vanguard Group Inc. raised its position in shares of Tenet Healthcare by 9.4% in the third quarter. Vanguard Group Inc. now owns 11,496,136 shares of the company’s stock valued at $327,180,000 after purchasing an additional 990,373 shares during the period. Partner Fund Management L.P. raised its position in shares of Tenet Healthcare by 22.2% in the second quarter. Partner Fund Management L.P. now owns 4,336,946 shares of the company’s stock valued at $145,591,000 after purchasing an additional 786,785 shares during the period. Morgan Stanley raised its position in shares of Tenet Healthcare by 165.3% in the second quarter. Morgan Stanley now owns 1,167,972 shares of the company’s stock valued at $39,208,000 after purchasing an additional 727,713 shares during the period. Point72 Asset Management L.P. bought a new position in shares of Tenet Healthcare in the third quarter valued at approximately $16,949,000. Finally, Hood River Capital Management LLC bought a new position in shares of Tenet Healthcare in the second quarter valued at approximately $15,094,000.
Shares of NYSE THC traded up $22.12 during mid-day trading on Monday, reaching $22.47. The company had a trading volume of 272,455 shares, compared to its average volume of 1,418,095. The company has a debt-to-equity ratio of 21.55, a current ratio of 1.06 and a quick ratio of 0.99. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of 27.74, a price-to-earnings-growth ratio of 1.12 and a beta of 0.87. Tenet Healthcare has a 12-month low of $12.45 and a 12-month high of $39.74.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Article: Debt-To-Equity Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.